porphycene

Subscribe to Selected New Research on porphycene

10 relevant articles (2 outcomes, 3 trials/studies) found for this Bio-Agent

Description: photodynamic therapy agent; structure given in first source

Also Known As:

21,22,23,24-Tetraazapentacyclo(16.2.1.12,5.18,11.112,15)tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Cheung, Nai-Ho: 1 article (07/2003)
2.	Lam, Sum-Wai: 1 article (07/2003)
3.	Yeung, Lam-Lung: 1 article (07/2003)
4.	Chang, Chi K: 1 article (07/2003)
5.	Lau, Yan-Kin: 1 article (07/2003)
6.	Leung, Wing-Nang: 1 article (07/2003)
7.	Mak, Nai-Ki: 1 article (07/2003)
8.	Huang, Dolly P: 1 article (07/2003)
9.	Kok, Tsz-Wai: 1 article (07/2003)
10.	Wong, Ricky Ngok-Shun: 1 article (07/2003)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2007 - "Some pharmacokinetic and phototherapeutic studies on experimental tumors after intravenous or topical application of lipophilic alkyl-substituted porphycene derivatives are known" 01/17/1996 - "Photodynamic therapy as short as 5 min after injection led to complete local tumor remission at a dosage of 1.4 mumol/kg for the porphycene CBPn" 10/01/1997 - "Targeting of the tumor microcirculation by photodynamic therapy with a synthetic porphycene." 01/01/2007 - "Taking into account all these features, porphycene PSs should be very useful for PDT of cancer and other biomedical applications." Get all the results and reference details, order at left...
2.	Leukemia L1210 05/01/2005 - "The photosensitizer 9-capronyloxytetrakis (methoxyethyl) porphycene localizes predominantly in the endoplasmic reticulum (ER) and, to a lesser extent, in mitochondria of murine leukemia L1210 cells" 12/01/2007 - "In this study, we followed the fate of mouse leukemia L1210 cells after photodamage to the endoplasmic reticulum (ER) using a porphycene photosensitizer, where Bcl-2 was among the PDT targets" Get all the results and reference details, order at left...
3.	Basal Cell Carcinoma (Rodent Ulcer) 02/01/1997 - "Topical application of a first porphycene dye for photodynamic therapy--penetration studies in human perilesional skin and basal cell carcinoma." Get all the results and reference details, order at left...
4.	Periodontal Diseases (Periodontal Disease) 07/01/2002 - "Selected bacterial strains that are responsible for periodontal diseases are efficiently inactivated by visible light irradiation in the presence of porphycene-polylysine conjugates" 07/01/2002 - "Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates." Get all the results and reference details, order at left...
5.	Fibrosarcoma 01/01/1989 - "The porphin isomer tetra-n-propyl-porphycene (TPP) was incorporated into unilamellar liposomes of dipalmitoylphosphatidylcholine and intravenously injected at a dose of 2 mg/kg to BALB/c mice bearing a MS-2 fibrosarcoma" Get all the results and reference details, order at left...
7 Diseases and 10 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	1-phenyl-3,3-dimethyltriazene (PDT)
2.	Unilamellar Liposomes
3.	1,2-Dipalmitoylphosphatidylcholine (Dipalmitoylphosphatidylcholine)
4.	Polylysine
5.	porphine
5 Drugs and Important Bio-Agents and 4 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Photochemotherapy (Photodynamic Therapy)
1 Therapies and Procedures and 3 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>